FdaApplication
NDA 216017
Identifiers
- fda_app_no: NDA216017
Properties
| Property | Value |
|---|---|
| applicant_name | BRACCO DIAGNOSTICS INC |
| application_type | NDA |
| approval_date | 2024-11-27 |
Products (13)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| IOMERVU | IOMEPROL | 52.5GM IODINE/150ML (350MG IODINE/ML) | SOLUTION;INTRAVENOUS |
| IOMERVU | IOMEPROL | 45GM IODINE/150ML (300MG IODINE/ML) | SOLUTION;INTRAVENOUS |
| IOMERVU | IOMEPROL | 17.5GM IODINE/50ML (350MG IODINE/ML) | SOLUTION;INTRAVENOUS |
| IOMERVU | IOMEPROL | 25GM IODINE/100ML (250MG IODINE/ML) | SOLUTION;INTRAVENOUS |
| IOMERVU | IOMEPROL | 60GM IODINE/150ML (400MG IODINE/ML) | SOLUTION;INTRAVENOUS |
| IOMERVU | IOMEPROL | 40GM IODINE/100ML (400MG IODINE/ML) | SOLUTION;INTRAVENOUS |
| IOMERVU | IOMEPROL | 35GM IODINE/100ML (350MG IODINE/ML) | SOLUTION;INTRAVENOUS |
| IOMERVU | IOMEPROL | 60GM IODINE/200ML (300MG IODINE/ML) | SOLUTION;INTRAVENOUS |
| IOMERVU | IOMEPROL | 15GM IODINE/50ML (300MG IODINE/ML) | SOLUTION;INTRAVENOUS |
| IOMERVU | IOMEPROL | 70GM IODINE/200ML (350MG IODINE/ML) | SOLUTION;INTRAVENOUS |
| IOMERVU | IOMEPROL | 20GM IODINE/50ML (400MG IODINE/ML) | SOLUTION;INTRAVENOUS |
| IOMERVU | IOMEPROL | 30GM IODINE/100ML (300MG IODINE/ML) | SOLUTION;INTRAVENOUS |
| IOMERVU | IOMEPROL | 80GM IODINE/200ML (400MG IODINE/ML) | SOLUTION;INTRAVENOUS |
13 products